The role of prevention in reducing the economic impact of ME/CFS in Europe : A report from the socioeconomics working group of the European network on ME/CFS (EUROMENE)

dc.contributor.authorPheby, Derek F.H.
dc.contributor.authorAraja, Diana
dc.contributor.authorBerkis, Uldis
dc.contributor.authorBrenna, Elenka
dc.contributor.authorCullinan, John
dc.contributor.authorDe Korwin, Jean Dominique
dc.contributor.authorGitto, Lara
dc.contributor.authorHughes, Dyfrig A.
dc.contributor.authorHunter, Rachael M.
dc.contributor.authorTrepel, Dominic
dc.contributor.authorWang-Steverding, Xia
dc.contributor.institutionFaculty of Pharmacy
dc.contributor.institutionInstitute of Microbiology and Virology
dc.date.accessioned2021-10-29T12:55:01Z
dc.date.available2021-10-29T12:55:01Z
dc.date.issued2021-04
dc.descriptionFunding Information: This research received no external funding. EUROMENE receives funding for networking activities from the COST programme (COST Action 15111), via the COST Association. Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
dc.description.abstractThis report addresses the extent to which there may be scope for preventive programmes for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and, if so, what economic benefits may accrue from the implementation of such programmes. We consider the economic case for prevention programmes, whether there is scope for preventive programmes for ME/CFS, and what are the health and economic benefits to be derived from the implementation of such programmes. We conclude that there is little scope for primary prevention programmes, given that ME/CFS is attributable to a combination of host and environmental risk factors, with host factors appearing to be most prominent, and that there are few identified modifiable risk factors that could be the focus of such programmes. The exception is in the use of agricultural chemicals, particularly organophosphates, where there is scope for intervention, and where Europe-wide programmes of health education to encourage safe use would be beneficial. There is a need for more research on risk factors for ME/CFS to establish a basis for the development of primary prevention programmes, particularly in respect of occupational risk factors. Secondary prevention offers the greatest scope for intervention, to minimise diagnostic delays associated with prolonged illness, increased severity, and increased costs.en
dc.description.statusPeer reviewed
dc.format.extent579239
dc.identifier.citationPheby, D F H, Araja, D, Berkis, U, Brenna, E, Cullinan, J, De Korwin, J D, Gitto, L, Hughes, D A, Hunter, R M, Trepel, D & Wang-Steverding, X 2021, 'The role of prevention in reducing the economic impact of ME/CFS in Europe : A report from the socioeconomics working group of the European network on ME/CFS (EUROMENE)', Medicina (Lithuania), vol. 57, no. 4, 388. https://doi.org/10.3390/medicina57040388
dc.identifier.doi10.3390/medicina57040388
dc.identifier.issn1010-660X
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/6770
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85105139873&partnerID=8YFLogxK
dc.language.isoeng
dc.relation.ispartofMedicina (Lithuania)
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectChronic fatigue syndrome
dc.subjectEconomic impact
dc.subjectME/CFS
dc.subjectMyalgic encephalomyelitis
dc.subjectPrevention
dc.subject3.2 Clinical medicine
dc.subject3.3 Health sciences
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database
dc.subjectGeneral Medicine
dc.titleThe role of prevention in reducing the economic impact of ME/CFS in Europe : A report from the socioeconomics working group of the European network on ME/CFS (EUROMENE)en
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
The_Role_of_Prevention_in_Reducing_the_Economic_Impact_of_ME_CFS_in_Europe.pdf
Size:
565.66 KB
Format:
Adobe Portable Document Format